Medicine and Dentistry
Out of Hospital Cardiac Arrest
100%
Defibrillator
82%
Prevalence
72%
Electrocardiogram
53%
Heart Arrest
45%
Positioning System
45%
Implantable Automatic Defibrillator
45%
Sudden Cardiac Death
42%
Diabetes
40%
Disease
40%
Volunteer
34%
Glucose Metabolism
34%
Impaired Glucose Tolerance
28%
Acute Heart Infarction
26%
Genetic Disorder
26%
Myocardial Infarction
22%
Familial Hypercholesterolemia
22%
Observational Study
22%
Glucose Tolerance
22%
Retrospective Study
22%
Brugada Syndrome
22%
Shock (Circulatory)
22%
Lipoprotein
22%
Myoclonus
22%
Heart Ventricle Arrhythmia
22%
Ryanodine Receptor 2
22%
Catecholaminergic Polymorphic Ventricular Tachycardia
22%
Cardiac Dysrhythmia
22%
Electrocardiographic Finding
22%
Clinical Trial
22%
Triage
22%
Virus Transformation
22%
Hormone Substitution
22%
Fibrinolysis
22%
Hypertriglyceridemia
22%
Venous Blood
22%
Mouth
22%
Postmenopause
22%
Pancreatitis
22%
DNA Extraction
22%
Buffer
22%
Copurification
22%
Biopsy Technique
22%
Coronary Care Unit
22%
Heart Disease
19%
Faintness
19%
Patient Referral
17%
Status Epilepticus
17%
Population Research
13%
Plasminogen Activator Inhibitor-1
12%
Biochemistry, Genetics and Molecular Biology
Genetic Screening
72%
Cardiac Arrest
57%
Prevalence
48%
Implantable Cardioverter-Defibrillator
48%
Familial Hypercholesterolemia
45%
Lipid
45%
Proband
45%
Long QT Syndrome
45%
Electrocardiogram
42%
Sudden Cardiac Death
41%
Genetics
36%
Automated External Defibrillator
34%
Cardiac Dysrhythmia
33%
Allele
28%
Postmenopause
27%
Lipoprotein Blood Level
27%
Brugada Syndrome
22%
Lipoprotein
22%
Vitamin D
22%
Osteolysis
22%
Clinical Trial
22%
Observational Study
22%
Glucose Test
22%
Glucose Tolerance Test
22%
Bone Density
22%
Information Retrieval
22%
Catecholaminergic Polymorphic Ventricular Tachycardia
22%
Atrioventricular Block
22%
Global Positioning System
22%
Glycosylated Hemoglobin
22%
Diacylglycerol Lipase
22%
Glycated Hemoglobin
22%
Climacterium
22%
Ryanodine Receptor 2
22%
Plasminogen Activator Inhibitor-1
22%
Fibrinolysis
22%
Impaired Glucose Tolerance
18%
Glucose Metabolism
17%
Pancreatic Lipase
16%
Triacylglycerol Lipase
16%
Channelopathy
16%
Body Size
13%
Plasminogen Activator
13%
Population Research
12%
KCNE1
11%
KCNE2
11%
Pedigree
7%
Glucose Blood Level
7%
LMNA
6%
Exome
5%
Pharmacology, Toxicology and Pharmaceutical Science
Prevalence
51%
Acute Heart Infarction
49%
Out of Hospital Cardiac Arrest
45%
Impaired Glucose Tolerance
31%
Diabetes Mellitus
23%
Familial Hypercholesterolemia
22%
Hemoglobin A1c
22%
Lipoprotein A
22%
Syndrome
22%
Congestive Cardiomyopathy
22%
Heart Ventricle Arrhythmia
22%
Heart Arrhythmia
22%
Myoclonus
22%
Myocarditis
22%
Heart Infarction
22%
Retrospective Study
22%
Heart Arrest
22%
Fibrinolytic Agent
22%
Replacement Therapy
22%
Myocardial Disease
22%
Epileptic State
17%
Plasminogen Activator Inhibitor 1
12%
Heart Supraventricular Arrhythmia
11%
Cardiovascular Risk
11%
Disease
9%
Plasminogen Activator
7%
Cardiovascular Disease
7%
Genetic Disorder
5%
Systolic Dysfunction
5%
Heart Ventricle Extrasystole
5%
Sudden Cardiac Death
5%
Left Ventricular Systolic Dysfunction
5%
Atrial Fibrillation
5%
QT Prolongation
5%
Congestive Heart Failure
5%
